Live Breaking News & Updates on Aisa Pharma Inc|Page 1

Stay updated with breaking news from Aisa pharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AISA Pharma Announces Upcoming Profervia® Data Presentations at AAN and EULAR

/PRNewswire/ Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,. ....

United States , Andrew Sternlicht , Aisa Pharma Inc , American Academy Of Neurology , Prnewswire Aisa Pharma Inc , European Alliance Of Associations , Positive Phase , Systemic Sclerosis , American Academy , Scientific Platform Session , Noveln Type Specific Calcium Channel Antagonist , Has Potent Activity , Which May Have Implications , Certain Neuropathic Pain , European Alliance , Novel Daily Oral Calcium Channel Blocker , N Channel Selectivity , Poster Discussion , Aisa Pharma ,

AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase 2 Data of Profervia® to treat Raynaud's Disease in Scleroderma Patients

AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase 2 Data of Profervia® to treat Raynaud's Disease in Scleroderma Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Andrew Sternlicht , Company Website , Aisa Pharma Inc , Wall Street , Data Safety Monitoring Board , Orphan Drug , Secondary Raynaud , Aisa Pharma ,